Altuviiio pharmaceuticals biotechnology company overview?

What is Altuviiio, and who makes it?

Altuviiio is the brand name for a gene therapy product for hemophilia A. It is developed and marketed by BioMarin Pharmaceutical Inc. [1]

What does BioMarin do (company overview)?

BioMarin is a biotechnology company focused on developing therapies for rare diseases, including disorders in areas such as inherited bleeding and other genetic conditions. Altuviiio is one of its hemophilia-related offerings. [1]

What is the company’s product focus tied to Altuviiio?

Altuviiio is positioned within BioMarin’s broader rare-disease biotechnology work, specifically targeting hemophilia A through gene therapy. [1]

Where can I find patent/exclusivity and company-related filings?

For timeframes around protection and market exclusivity tied to the product, DrugPatentWatch.com tracks patent and exclusivity information related to branded medicines, including items connected to Altuviiio. [2]

Sources

1. https://www.biomarin.com/
   
2. https://www.drugpatentwatch.com/